Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/1636
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lems, W. | - |
dc.contributor.author | Lodder, M. | - |
dc.contributor.author | Lips, P. | - |
dc.contributor.author | Bijlsma, J. | - |
dc.contributor.author | GEUSENS, Piet | - |
dc.contributor.author | Schrameijer, N. | - |
dc.contributor.author | van de Ven, C. | - |
dc.contributor.author | Dijkmans, B. | - |
dc.date.accessioned | 2007-06-15T09:23:04Z | - |
dc.date.available | 2007-06-15T09:23:04Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | OSTEOPOROSIS INTERNATIONAL, 17(5). p. 716-723 | - |
dc.identifier.issn | 0937-941X | - |
dc.identifier.uri | http://hdl.handle.net/1942/1636 | - |
dc.description.abstract | Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of patients with the same underlying diseases who receive chronic low-dose prednisone treatment. The objective of the investigation reported here was, therefore, to study the effect of alendronate on bone mineral density (BMD) of the lumbar spine and hips in patients with rheumatoid arthritis (RA) who are on chronic low-dose prednisone treatment..... | - |
dc.language.iso | en | - |
dc.publisher | Springer | - |
dc.subject.other | Alendronate - Bone mineral density - Prednisone - Rheumatoid arthritis | - |
dc.title | Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 723 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 716 | - |
dc.identifier.volume | 17 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1007/s00198-005-0037-2 | - |
dc.identifier.isi | 000236829600009 | - |
item.fullcitation | Lems, W.; Lodder, M.; Lips, P.; Bijlsma, J.; GEUSENS, Piet; Schrameijer, N.; van de Ven, C. & Dijkmans, B. (2006) Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.. In: OSTEOPOROSIS INTERNATIONAL, 17(5). p. 716-723. | - |
item.fulltext | No Fulltext | - |
item.validation | ecoom 2007 | - |
item.contributor | Lems, W. | - |
item.contributor | Lodder, M. | - |
item.contributor | Lips, P. | - |
item.contributor | Bijlsma, J. | - |
item.contributor | GEUSENS, Piet | - |
item.contributor | Schrameijer, N. | - |
item.contributor | van de Ven, C. | - |
item.contributor | Dijkmans, B. | - |
item.accessRights | Closed Access | - |
crisitem.journal.issn | 0937-941X | - |
crisitem.journal.eissn | 1433-2965 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
47
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
51
checked on Sep 26, 2024
Page view(s)
66
checked on Jul 28, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.